Browsing by Author Correa-Rotter, R

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)Citation
2017Comparison of Exposure Response Relationship of Atrasentan between North American and Asian PopulationsPerkovic, Vlado; Andress, Dennis; Brennan, John J; Coll, Blai; Correa-Rotter, R; Davis, J; et al, Various; Heerspink, Hiddo Lambers; Idler, K; Kohan, Donald; Makino, Hirofumi; The George Institute for Global HealthComparison of Exposure Response Relationship of Atrasentan between North American and Asian Populations, Diabetes, Obesity and Metabolism, vol.19, 4, 2017,pp 545-552
2017Complications of chronic kidney disease: current state, knowledge gaps, and strategy for actionWhite, Sarah; Alrukhaimi, Mona; Ashuntantang, Gloria; Basnet, Shakti; Bello, A; Correa-Rotter, R; Douthat, Walter G.; Kazancioglu, Rumeyza; Kottgen, Anna; Moe, O; Nangaku, Masaomi; Powe, Neil R.; Wheeler, David; The George Institute for Global HealthComplications of chronic kidney disease: current state, knowledge gaps, and strategy for action, Kidney International Supplements, vol.7, 2, 2017,pp 122-129
2014The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathyPerkovic, Vlado; Andress, Dennis; Brennan, John J; Coll, Blai; Correa-Rotter, R; de Zeeuw, Dick; et al, Various; Houser, Mark; Kohan, Donald; Lambers Heerspink, Hiddo; Makino, Hirofumi; Tang, Hui; The George Institute for Global HealthThe endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy, Journal of the American Society of Nephrology, vol.25, 5, 2014,pp 1083-1093
2017Genetic and environmental risk factors for chronic kidney diseasePollock, Carol; Correa-Rotter, R; et al, Various; Kretzler, Matthias; Langham, Robyn G.; Nangaku, Masaomi; Obrador, Gregorio; Pecoits-Filho, Roberto; Rossert, Jerome; Schultheiss, Ulla T.; Stenvinkel, Peter; Northern Clinical School: MedicineGenetic and environmental risk factors for chronic kidney disease, Kidney International Supplements, vol.7, 2, 2017,pp 88-106
2017Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled TrialPerkovic, Vlado; Andress, Dennis; Brennan, John J; Coll, Blai; Correa-Rotter, R; et al, Various; Heerspink, Hiddo Lambers; Houser, Mark; Kohan, Donald; Makino, Hirofumi; Pritchett, Yili; Webb, David J.; The George Institute for Global HealthLongitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial, Drugs in R and D, vol.17, 3, 2017,pp 441-448
2016Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markersPerkovic, Vlado; Andress, Dennis; Brennan, John J; Coll, Blai; Correa-Rotter, R; de Zeeuw, Dick; et al, Various; Hou, Fanfan; Kohan, Donald; Schievink, Bauke; Smink, Paul A; The George Institute for Global HealthPrediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers, European Journal of Preventive Cardiology, vol.23, 7, 2016,pp 758-768
2015Predictors of Atrasentan-Associated Fluid Retention and Change in Albuminuria in Patients with Diabetic NephropathyPerkovic, Vlado; Andress, Dennis; Brennan, John J; Coll, Blai; Correa-Rotter, R; et al, Various; Heerspink, Hiddo Lambers; Hou, Fanfan; Kitzman, Dalane W; Kohan, Donald; Makino, Hirofumi; Remuzzi, Giuseppe; The George Institute for Global HealthPredictors of Atrasentan-Associated Fluid Retention and Change in Albuminuria in Patients with Diabetic Nephropathy, Clinical Journal of the American Society of Nephrology, vol.10, 9, 2015,pp 1568-1574